Mainz Biomed N.V.
$0.47
▼
-3.96%
2026-04-21 09:02:01
mainzbiomed.com
NCM: QUCY
Explore Mainz Biomed N.V. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.89 M
Current Price
$0.47
52W High / Low
$4.43 / $0.4
Stock P/E
—
Book Value
$0.62
Dividend Yield
—
ROCE
-252.7%
ROE
-4.88%
Face Value
—
EPS
$-2.7
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
—
Beta
0.47
Debt / Equity
400.8
Current Ratio
0.5
Quick Ratio
0.44
Forward P/E
—
Price / Sales
10.32
Enterprise Value
$7.23 M
EV / EBITDA
-0.56
EV / Revenue
13.46
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Agilent Technologies, Inc. | $122.3 | 26.99 | $34.7 B | 0.84% | 14.25% | 19.95% | $160.27 / $99.12 | $24.44 |
| 2. | Illumina, Inc. | $131.09 | 24.09 | $19.95 B | — | 16.15% | 33.36% | $155.53 / $69.83 | $17.8 |
| 3. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
| 4. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
| 5. | Natera, Inc. | $206.53 | — | $29.47 B | — | -15.84% | -14.32% | $256.36 / $131.81 | $12.26 |
| 6. | GeneDx Holdings Corp. | $69.71 | — | $1.92 B | — | -3.15% | -7.6% | $170.87 / $55.17 | $10.54 |
| 7. | Fulgent Genetics, Inc. | $16.18 | — | $481.31 M | — | -8.07% | -5.51% | $31.04 / $13.46 | $35.78 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.54 M | 0.89 M | 0.9 M | 0.53 M |
| Operating Profit | -12.97 M | -18.45 M | -26.64 M | -26.44 M |
| Net Profit | -16.21 M | -21.6 M | -26.3 M | -26.39 M |
| EPS in Rs | -1.3 | -1.73 | -2.1 | -2.11 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.33 M | 13.5 M | 15.41 M | 20.24 M |
| Total Liabilities | 4.69 M | 7.5 M | 12.16 M | 6.14 M |
| Equity | 0.64 M | 6 M | 3.25 M | 14.1 M |
| Current Assets | 1.84 M | 8.02 M | 8.98 M | 18.38 M |
| Current Liabilities | 3.69 M | 6.18 M | 9.24 M | 4.24 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.98 M | -17.33 M | -21.94 M | -14.77 M |
| Investing CF | -1.03 M | -0.2 M | -1.9 M | -0.66 M |
| Financing CF | 6.76 M | 16.79 M | 14.23 M | 23.94 M |
| Free CF | -12.03 M | -17.58 M | -23.84 M | -15.43 M |
| Capex | -1.05 M | -0.25 M | -1.9 M | -0.66 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0.17% | 69% | — | — |
| Earnings Growth % | 17.86% | 0.35% | — | — |
| Profit Margin % | -2415.99% | -2936.5% | -4979.9% | — |
| Operating Margin % | -2063.77% | -2975.47% | -4990.6% | — |
| Gross Margin % | 64.31% | 56.91% | 34.38% | — |
| EBITDA Margin % | -2232.3% | -2777.25% | -4853.62% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.